Literature DB >> 30840047

Prescription Drugs-List Price, Net Price, and the Rebate Caught in the Middle.

Stacie B Dusetzina1,2, Peter B Bach3.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30840047     DOI： 10.1001/jama.2019.2445

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  11 in total

1.  Decomposition Analysis of Spending and Price Trends for Biologic Antirheumatic Drugs in Medicare and Medicaid.

Authors:  Natalie McCormick; Zachary S Wallace; Chana A Sacks; John Hsu; Hyon K Choi
Journal:  Arthritis Rheumatol       Date:  2020-01-06       Impact factor: 10.995

2.  US Spending Associated With Transition From Daily to 3-Times-Weekly Glatiramer Acetate.

Authors:  Benjamin N Rome; Frazer A Tessema; Aaron S Kesselheim
Journal:  JAMA Intern Med       Date:  2020-09-01       Impact factor: 21.873

3.  Budget Impact of Adaptive Abiraterone Therapy for Castration-Resistant Prostate Cancer.

Authors:  Neil T Mason; Jason M Burkett; Ryan S Nelson; Julio M Pow-Sang; Robert A Gatenby; Timothy Kubal; John W Peabody; G Douglas Letson; Howard L McLeod; Jingsong Zhang
Journal:  Am Health Drug Benefits       Date:  2021-03

4.  Payment incentives and the use of higher-cost drugs: a retrospective cohort analysis of intravenous iron in the Medicare population.

Authors:  Bryan C Hambley; Kelly E Anderson; Satish P Shanbhag; Aditi P Sen; Gerard Anderson
Journal:  Am J Manag Care       Date:  2020-12       Impact factor: 2.229

5.  Association of Drug Rebates and Competition With Out-of-Pocket Coinsurance in Medicare Part D, 2014 to 2018.

Authors:  Darius Lakdawalla; Meng Li
Journal:  JAMA Netw Open       Date:  2021-05-03

6.  Medicare Part D Plans Rarely Cover Brand-Name Drugs When Generics Are Available.

Authors:  Stacie B Dusetzina; Juliette Cubanski; Leonce Nshuti; Sarah True; Jack Hoadley; Drew Roberts; Tricia Neuman
Journal:  Health Aff (Millwood)       Date:  2020-08       Impact factor: 9.048

7.  Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs.

Authors:  Benjamin N Rome; William B Feldman; Rishi J Desai; Aaron S Kesselheim
Journal:  JAMA Netw Open       Date:  2021-05-03

8.  Pharmacologic, Dietary, and Psychological Treatments for Irritable Bowel Syndrome With Constipation: Cost Utility Analysis.

Authors:  Eric D Shah; Jessica K Salwen-Deremer; Peter R Gibson; Jane G Muir; Shanti Eswaran; William D Chey
Journal:  MDM Policy Pract       Date:  2021-01-18

9.  Changes in Drug List Prices and Amounts Paid by Patients and Insurers.

Authors:  Eric J Yang; Emilio Galan; Robert Thombley; Andrew Lin; Jaeyun Seo; Chien-Wen Tseng; Jack S Resneck; Peter B Bach; R Adams Dudley
Journal:  JAMA Netw Open       Date:  2020-12-01

10.  Association of Branded Prescription Drug Rebate Size and Patient Out-of-Pocket Costs in a Nationally Representative Sample, 2007-2018.

Authors:  Kai Yeung; Stacie B Dusetzina; Anirban Basu
Journal:  JAMA Netw Open       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.